| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 30 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 30 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 30 |
| 3 | DOXORUBICIN | 30 |
| 4 | CARBOPLATIN | 27 |
| 5 | ETOPOSIDE | 21 |
| 6 | MELPHALAN HYDROCHLORIDE | 20 |
| 7 | CYTARABINE | 18 |
| 8 | METHOTREXATE SODIUM | 17 |
| 9 | METHOTREXATE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELIVALDOGENE AUTOTEMCEL | 1 | 0.1000 |
| 1 | IBRITUMOMAB TIUXETAN | 5 | 0.0033 |
| 2 | MINERAL OIL | 3 | 0.0020 |
| 3 | TOPOTECAN | 11 | 0.0018 |
| 4 | TRETINOIN | 8 | 0.0010 |
| 5 | DACTINOMYCIN | 2 | 0.0009 |
| 6 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 7 | CARMUSTINE | 4 | 0.0008 |
| 8 | IDECABTAGENE VICLEUCEL | 1 | 0.0008 |
| 9 | MELPHALAN HYDROCHLORIDE | 20 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 38 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 29 |
| 2 | Platinum-based Drug [EPC] | 27 |
| 3 | Corticosteroid [EPC] | 24 |
| 4 | Topoisomerase Inhibitor [EPC] | 21 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 6 | Microtubule Inhibitor [EPC] | 15 |
| 7 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 13 |
| 8 | Sulfonamide Antimicrobial [EPC] | 13 |
| 9 | Thalidomide Analog [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 2 | 0.0009 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 2 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 12 | 0.0006 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 5 | 0.0005 |
| 4 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Topoisomerase Inhibitor [EPC] | 21 | 0.0003 |
| 6 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 7 | BCL-2 Inhibitor [EPC] | 11 | 0.0002 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 9 | Alkylating Drug [EPC] | 38 | 0.0002 |